Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/1997
11/05/1997EP0804564A1 Neural axon outgrowth modulators
11/05/1997EP0804562A1 Connective tissue growth factor-2
11/05/1997EP0804561A1 Regulated transcription of targeted genes and other biological events
11/05/1997EP0804552A1 Redirection of cellular immunity by receptor chimeras
11/05/1997EP0804547A1 Unique associated kaposi's sarcoma virus sequences and uses thereof
11/05/1997EP0804546A1 Human prostatic specific reductase
11/05/1997EP0804489A1 Antigenic preparation for treatment or prevention of helicobacter infection
11/05/1997EP0804487A2 Bispecific antigen-binding molecules
11/05/1997EP0804486A2 Granulocyte chemotactic protein
11/05/1997EP0804484A1 Antigenic polypeptide sequence of factor viii, fragments and/or epitopes thereof
11/05/1997EP0804483A1 Isolated peptides derived from mage tumor rejection antigen precursors which complex with hla-a2 molecules
11/05/1997EP0804482A1 Cytokines that bind the cell surface receptor hek
11/05/1997EP0804481A1 Somatostatin derivatives and their radiolabelled products
11/05/1997EP0804480A1 Purified thrombopoietin and method of making it
11/05/1997EP0804479A1 Method of treating diabetes mellitus using kgf
11/05/1997EP0804478A1 Growth factor analogs
11/05/1997EP0804476A1 PORE FORMING PEPTIDES FROM $i(GEOLYCOSA RIOGRANDE)
11/05/1997EP0804475A1 Polypeptides and their use in treatment and prophylaxis of auto-immune disease
11/05/1997EP0804473A1 Methods and compositions for differential diagnosis of acute and chronic hepatitis c virus infection
11/05/1997EP0804471A1 Gnrh antagonists
11/05/1997EP0804470A1 Thrombin inhibitors, the preparation thereof and the use thereof for therapeutical, prophylactic and diagnostic applications
11/05/1997EP0804469A1 Novel peptide
11/05/1997EP0804468A1 Conformationally constrained backbone cyclized peptide analog
11/05/1997EP0804467A1 Isolated, truncated nucleic acid molecules which code for gage tumor rejection antigen
11/05/1997EP0804466A1 Novel tetrapeptides, their manufacture and use
11/05/1997EP0804465A1 Novel elastase inhibitors
11/05/1997EP0804464A1 Aromatic heterocyclic derivatives as enzyme inhibitors
11/05/1997EP0804463A1 Neurokinine (tachykinine) antagonists
11/05/1997EP0804461A1 Process for folding of proteins like recombinant hirudin or epidermal growth factor
11/05/1997EP0804459A1 Therapeutic compound - fatty acid conjugates
11/05/1997EP0804458A1 Development of dna probes and immunological reagents specific for cell surface-expressed molecules and transformation-associated genes
11/05/1997EP0804456A1 Peptide nucleic acid conjugates
11/05/1997EP0804452A1 Recombinant c140 receptor and its agonists and antagonists
11/05/1997EP0804451A1 Lung cancer marker
11/05/1997EP0804283A1 Aqueous solvent encapsulation method, apparatus and microcapsules
11/05/1997EP0804254A1 Heat treated blood plasma proteins
11/05/1997EP0804248A2 Chemically modified interferon
11/05/1997EP0804244A1 Compositions including heme-containing proteins and methods relating thereto
11/05/1997EP0804240A1 Compounds for preventing multidrug resistance in cancer cells containing protein kinase inhibitors
11/05/1997EP0804237A1 Humanized antibodies against leukocyte adhesion molecule vla-4
11/05/1997EP0804236A1 Use of anti-tnf antibodies as drugs in treating diseases involving elevated interleukin-6 serum levels
11/05/1997EP0804235A1 Antibodies to p-selectin and their uses
11/05/1997EP0804229A2 Composition containing amlodipine, or a salt or felodipine and anace inhibitor
11/05/1997EP0804228A1 The use of activated protein c for preparing a pharmaceutical preparation
11/05/1997EP0804227A2 New applications of lysozyme dimer
11/05/1997EP0804226A1 Human choline acetyltransferase
11/05/1997EP0804225A1 Pharmaceutical compositions comprising a superoxide dismutase
11/05/1997EP0804224A1 A stabilized pharmaceutical formulation comprising a growth hormone and lys-x
11/05/1997EP0804223A1 Hgh containing pharmaceutical compositions
11/05/1997EP0804222A1 Accessory factor function for interferon gamma and its receptor
11/05/1997EP0804221A1 Methods and kits for stimulating production of megakaryocytes and thrombocytes
11/05/1997EP0804220A1 Pharmaceutical formulations comprising a salt of clavulanic acid, vancomycin and one or more beta-lactam antibiotics
11/05/1997EP0804219A1 Inhibin compositions and methods of use thereof
11/05/1997EP0804218A1 Product and process for regulating signal transduction pathways
11/05/1997EP0804217A2 Antagonists of alpha-melanocyte stimulating hormone and methods based thereon
11/05/1997EP0804216A1 Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein
11/05/1997EP0804214A1 Growth differentiation factor-6
11/05/1997EP0804202A1 Estrogens and parathyroid hormone for treating osteoporosis
11/05/1997EP0804182A2 Use of gabapentin in the treatment of anxiety and panic
11/05/1997EP0804180A1 Method of inhibiting cathepsin k
11/05/1997EP0804177A1 Use of nitric oxide-releasing agents for reducing metastasis risk
11/05/1997EP0804163A1 Improved method for stabilization of biological substances during drying and subsequent storage and compositions thereof
11/05/1997EP0804088A1 Stabilized composition comprising colistin sulfate
11/05/1997EP0804076A1 Gene therapy involving concurrent and repeated administration of adenoviruses and immunosuppressive agents
11/05/1997EP0804070A1 Isolation of components of interest from milk
11/05/1997EP0635068B1 Amplification of human mdm2 gene in human tumors
11/05/1997EP0432203B1 Legionellosis vaccines and methods for their production
11/05/1997CN1164258A Nucleotide sequences of HIV-10 type (or subtype) O retrovirus antigens
11/05/1997CN1164237A New peptides with immunomodulatory effects
11/05/1997CN1164194A Remedy for diseases caused by IL-6 production
11/05/1997CN1164193A Human chemokine polypeptides
11/05/1997CN1164192A Multicatalytic protease inhibitors
11/05/1997CN1164191A Mutant enterotoxin effective as non-toxic oral adjuvant
11/05/1997CN1163935A Five urokinase variant gene and its expression in colibacillus
11/05/1997CN1163934A Protein with thrombocytopoietic factor active
11/05/1997CN1163933A Protein with thrombocytopoietic factor active
11/05/1997CN1163780A Osteogenesis stimulin injection and its preparing process
11/05/1997CN1036343C Process for preparing luteinizing hormone releasing hormone and antagonistic analogue
11/04/1997US5684711 System, method, and computer program for at least partially automatically generating chemical compounds having desired properties
11/04/1997US5684147 Therapeutic anti-HIV anti-viral oligonucleotides and pharmaceutical formulations thereof
11/04/1997US5684136 Fusion proteins and immunoglobulins
11/04/1997US5684133 Neurite growth regulatory factors, antibodies thereto, and pharmaceutical compositions
11/04/1997US5684129 Interferon receptor binding peptides
11/04/1997US5684128 Dehydration, reduction and etherification then deacylation to form amino groups on cyclic oligopeptides
11/04/1997US5684127 Tetrapeptides deriving from dalbaheptide antibiotics
11/04/1997US5684016 Method of treating cardiac insufficiency
11/04/1997US5684010 Viricides
11/04/1997US5683990 Administering azt and 2-amino-9-(2-hydroxyethoxymethyl) purine in treatment of aids
11/04/1997US5683987 Multidrug resistance phenotypes and nucleotide sequences
11/04/1997US5683984 Enteral tube feeding composition with a native micellar casein protein component
11/04/1997US5683983 Peptides and compounds that bind to the IL-5 receptor
11/04/1997US5683982 Mixture of peptide and lipid for respiratory distress
11/04/1997US5683981 Cyclic bridged analogs of α-MSH and methods thereof
11/04/1997US5683910 Human phosphorylase kinase gamma subunit
11/04/1997US5683905 Vectors and cell lines capable of correctly splicing exon regions
11/04/1997US5683902 Human papilloma virus inhibition by a hairpin ribozyme
11/04/1997US5683892 DNA encoding recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders
11/04/1997US5683890 Bacteriocins from Streptococcus thermophilus
11/04/1997US5683887 Immunochemical detection of in vivo advanced glycosylation endproducts
11/04/1997US5683886 Tumor rejection antigens which correspond to amino acid sequences in tumor rejection antigen precursor bage, and uses thereof